A prognostic biomarker NRG1 promotes U-87 MG glioblastoma cell malignancy by inhibiting autophagy via ERBB2/AKT/mTOR pathway

• Published in: Journal of cellular biochemistry Vol. 124; no. 9; pp. 1273 - 1288
• Main Authors: Lin, Jia-Zhe, Lin, Nuan, Zhao, Wei-Jiang
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01-09-2023
• Subjects: AKT protein; Autophagy; Biomarkers; Brain cancer; Brain tumors; Cadaverine; Cell migration; ErbB-2 protein; Flow cytometry; Gene expression; Genomes; Glioblastoma; Immunofluorescence; Prognosis; Regression; Staining; TOR protein; Wound healing; computational biology; prognostic; neuregulin-1; autophagy; glioblastoma
• ISSN: 0730-2312; 1097-4644
• DOI: 10.1002/jcb.30444

Glioblastoma (GBM) is the most common and aggressive primary brain malignancy. Studies have shown that autophagy-related (ATG) genes play important roles in regulating GBM malignancy. However, the mechanism still needs to be fully elucidated. Based on clinical and gene expression information of GBM patients downloaded from The The Cancer Genome Atlas database, Kaplan-Meier, univariate Cox regression, least absolute shrinkage and selection operator regression and multivariate Cox regression were applied to construct a risk signature for GBM prognosis, followed by validation using receiver operating characteristic analysis. Next, Cell Counting Kit-8, wound healing assay, flow cytometry, monodansyl cadaverine autophagy staining assay, immunofluorescence staining and western blot, either in the absence or presence of ERBB2/AKT/mTOR inhibitors, were carried out in GBM U87 cell line to explore molecular pathway underlying GBM malignancy. A three-ATG-gene signature (HIF1A, ITGA3, and NGR1) was constructed for GBM prognosis with the greatest contribution from NRG1. In vitro experiments showed that NRG1 promoted U87 cell migration and proliferation by inhibiting autophagy, and ERBB2/AKT/mTOR is a downstream pathway that mediates the autophagy-inhibitory effects of NRG1. We constructed an ATG gene prognostic model for GBM and demonstrated that NRG1 inhibited autophagy by activating ERBB2/AKT/mTOR, promoting GBM malignancy, thus providing new insights into the molecular contribution of autophagy in GBM malignancy.